A top-tier news organization like the New York Times, Wall Street Journal, or ProPublica is likely to publish a deep investigative story about ketamine clinic chains by end of 2026. The story will probably focus on patient safety incidents, sloppy prescribing, or business pressure overriding medical judgment. This matters because ketamine is currently the only legal psychedelic-style treatment widely available, and millions of people are using it.
Sharpened to name qualifying outlets and resolution criteria. The KAP survey literature documents practice-pattern chaos, active DEA interest supplies a news hook, and the trauma-theory backlash piece demonstrates editorial appetite for psychedelic-skeptic stories. Convergence between journalist and dea_officer agents in Rounds 2-3 strengthens the base rate. Resolves YES on publication of a single qualifying investigation; NO otherwise. Confidence of 0.74 is reasonable given a 6-month window and multiple outlets known to have reporters on the beat.